Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Finished Goods (2024)

Whitehawk Therapeutics (WHWK) has disclosed Finished Goods for 1 consecutive years, with $1.8 million as the latest value for Q4 2024.

  • On a quarterly basis, Finished Goods changed N/A to $1.8 million in Q4 2024 year-over-year; TTM through Dec 2024 was $1.8 million, a N/A change, with the full-year FY2024 number at $1.8 million, changed N/A from a year prior.
  • Finished Goods was $1.8 million for Q4 2024 at Whitehawk Therapeutics.
  • In the past five years, Finished Goods ranged from a high of $1.8 million in Q4 2024 to a low of $1.8 million in Q4 2024.